COMMUNIQUÉS West-GlobeNewswire

Aino Health AB (publ): Smart Health Management brought big rewards for Tornio
23/01/2019
January 23 2019 The municipality of Tornio is a forerunner in the strategic utilization of health management. The work, started ten years ago, has yielded solid results. Anja Huhtanen, HR Manager for Tornio, says that [...]
Saniona reports UPenn to continue cocaine addiction study with NS2359 at higher dose after blinded interim analysis
23/01/2019
PRESS RELEASE January 23, 2019 University of Pennsylvania Treatment Research Center continues investigator-initiated study Decision based on interim analysis of blinded data for first 50 patients Good scientific [...]
ASLAN Announces Publication of New Pre-Clinical Data Demonstrating the Activity of Varlitinib in TNBC Cell Lines
23/01/2019
SINGAPORE, Jan. 23, 2019 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (NASDAQ:ASLN, TPEx:6497), a clinical-stage biopharmaceutical company targeting cancers that are both highly prevalent in Asia and orphan indications in [...]
ObsEva SA Reports Initial Good Safety of OBE022 in Pregnant Women with Preterm Labour and Announces Start of Part B of the PROLONG Trial
23/01/2019
Geneva, Switzerland and Boston, MA – January 23, 2018 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious [...]
Hemispherx Biopharma’s CEO to Present at the 15th Annual NobleConXV Conference
23/01/2019
OCALA, Fla., Jan. 23, 2019 (GLOBE NEWSWIRE) -- (NYSE American: HEB) — Hemispherx Biopharma Inc., an immuno-pharma R&D and emerging commercial growth company focused on unmet medical needs in immunology, announced [...]
Management Cease Trade Order Update
23/01/2019
HALIFAX, Nova Scotia, Jan. 22, 2019 (GLOBE NEWSWIRE) -- MedMira Inc. (TSXV: MIR) (“MedMira” or the “Company”) provides an update with respect to the previously announced management cease trade order (the “MCTO”) issued [...]
Bellerophon Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
22/01/2019
WARREN, N.J., Jan. 22, 2019 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, today announced that it intends to offer and sell [...]
Rexahn Announces Proposed Public Offering of Common Stock and Warrants
22/01/2019
ROCKVILLE, Md., Jan. 22, 2019 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN) today announced that it intends to offer and sell shares of its common stock and warrants to purchase shares of its [...]
Flexion Therapeutics Names Christina Willwerth Chief Strategy Officer
22/01/2019
BURLINGTON, Mass., Jan. 22, 2019 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that Christina Willwerth has been named Chief Strategy Officer. Ms. Willwerth joined Flexion in June 2009, [...]
Wright Medical Group N.V. to Host Fourth Quarter 2018 Earnings Conference Call
22/01/2019
Tuesday, February 26, 2019 at 3:30 p.m. Central / 4:30 p.m. Eastern AMSTERDAM, The Netherlands, Jan. 22, 2019 (GLOBE NEWSWIRE) -- Wright Medical Group N.V. (NASDAQ: WMGI) today announced that it will host a conference [...]
ChromaDex Prepared to Proceed with Patent Infringement Action Against Elysium Health
22/01/2019
ChromaDex to move forward with patent infringement action, following unsuccessful challenge by Elysium Health during Inter Partes Review (IPR) LOS ANGELES, Jan. 22, 2019 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC [...]
Selecta Biosciences Announces Proposed Public Offering of Common Stock
22/01/2019
WATERTOWN, Mass., Jan. 22, 2019 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (Nasdaq: SELB) (“Selecta”), a clinical-stage biotechnology company focused on unlocking the full potential of biologic therapies based on its [...]
NeuroMetrix Reports Publication of Randomized Controlled Trial of Quell Wearable Pain Relief in Chronic Low Back Pain
22/01/2019
WALTHAM, Mass., Jan. 22, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) today reported publication of results from a randomized controlled trial of Quell ® in subjects with chronic low back pain in the journal [...]
SuperSonic Imagine to present Aixplorer® MACH 30 at the Arab Health Exhibition in Dubai from 28 to 31 January 2019
22/01/2019
AIX-EN-PROVENCE, France, Jan. 22, 2019 (GLOBE NEWSWIRE) -- SuperSonic Imagine (Euronext: SSI, FR0010526814), a company specialising in ultrasound medical imaging, will for the first time present its new Aixplorer® MACH [...]
SuperSonic Imagine présentera Aixplorer® MACH 30 au Congrès Arab Health du 28 au 31 janvier 2019 à Dubaï
22/01/2019
AIX-EN-PROVENCE, France, 22 janv. 2019 (GLOBE NEWSWIRE) -- SuperSonic Imagine (Euronext : SSI, FR0010526814, éligible PEA-PME), entreprise spécialisée dans l’imagerie médicale par échographie, présentera, pour la [...]
Healthcare Industry Expert Dr. Daniel Castillo Joins Matrix Medical Network as Chief Medical Officer
22/01/2019
SCOTTSDALE, Ariz., Jan. 22, 2019 (GLOBE NEWSWIRE) -- Matrix Medical Network, a leading provider of in-home and mobile health clinic assessments and care management, has announced that Dr. Daniel Castillo has joined the [...]
Genmab Announces Initiation of U.S. FDA Regulatory Submission for Label Expansion of Daratumumab in Combination with Lenalidomide and Dexamethasone in Front Line Multiple Myeloma
22/01/2019
Company Announcement First part of regulatory package submitted to the U.S. FDA for label expansion of daratumumab in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma [...]
Novel Augmented Reality Surgery Technology Comes to Hamilton Operating Room
22/01/2019
Mariner Endosurgery's LaparoGuard System Lands at Hamilton General Hospital Hamilton, ON, Jan. 22, 2019 (GLOBE NEWSWIRE) -- Mariner Endosurgery, an innovative Canadian medical device company leading commercialization of [...]
Misonix to Report Fiscal 2019 Second Quarter Financial Results and Host Conference Call and Webcast on February 6
22/01/2019
FARMINGDALE, N.Y., Jan. 22, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, [...]

Pages